College of Stomatology, Key Lab of Oral Biomedicine of Shandong Province, Shandong University, Jinan, P. R. China.
Mol Pharm. 2010 Aug 2;7(4):1283-90. doi: 10.1021/mp100073s.
The small heat shock protein 27 (Hsp27) is a molecular chaperone that is involved in a variety of cellular functions in cancer cells. The purpose of this research is to study Hsp27 in vitro metastatic behaviors of head and neck squamous cell carcinoma cells (HNSCC). The expression of Hsp27 in primary and metastatic cell lines derived from the primary HNSCC and a synchronous lymph node metastasis in the same patient was determined using real-time PCR and Western blotting. Proliferation of the primary and metastatic HNSCC cell lines was evaluated using the MTS proliferation assay. Metastatic behavior was assessed using migration and invasion assays. SiRNA knockdown of Hsp27 was performed in the highly migratory metastatic HNSCC cell line. MTS assays showed that the primary (UM-SCC-22A) and metastatic (UM-SCC-22B) HNSCC have similar proliferation rates. However, UM-SCC-22B derived from the metastasis showed 2.3- to 3.6-fold higher migration ability and 2-fold higher invasion ability than UM-SCC-22A. Real-time PCR demonstrated that Hsp27 mRNA is 22.4-fold higher in metastatic UM-SCC-22B than primary UM-SCC-22A. Similarly, Western blotting showed that Hsp27 is rarely detectable in UM-SCC-22A whereas UM-SCC-22B expresses a 25-fold higher level of Hsp27 protein. SiRNA-mediated knockdown of Hsp27 in UM-SCC-22B reduced Hsp27 mRNA expression by nearly 6-fold and protein expression by 23-fold. Furthermore, siRNA knockdown of Hsp27 decreased metastatic behaviors of UM-SCC-22B by 3- to 4-fold in migration and 2-fold in cell invasion reducing cell invasion and migration to levels similar to the primary HNSCC UM-SCC-22A. These data indicate that Hsp27 may regulate metastatic potential of HNSCC cancer cells. Targeting Hsp27 may decrease metastasis in head and neck squamous cell cancer cells.
小热休克蛋白 27(Hsp27)是一种分子伴侣,参与癌细胞的多种细胞功能。本研究旨在研究 Hsp27 在头颈部鳞状细胞癌(HNSCC)细胞体外转移行为中的作用。使用实时 PCR 和 Western blot 测定源自原发性 HNSCC 及其在同一患者中同步淋巴结转移的原代和转移细胞系中 Hsp27 的表达。使用 MTS 增殖测定评估原代和转移性 HNSCC 细胞系的增殖。通过迁移和侵袭测定评估转移行为。在高迁移性转移性 HNSCC 细胞系中进行 Hsp27 的 siRNA 敲低。MTS 测定表明,原发性(UM-SCC-22A)和转移性(UM-SCC-22B)HNSCC 的增殖率相似。然而,源自转移的 UM-SCC-22B 显示出 2.3-3.6 倍更高的迁移能力和 2 倍更高的侵袭能力比 UM-SCC-22A。实时 PCR 表明 Hsp27 mRNA 在转移性 UM-SCC-22B 中比原发性 UM-SCC-22A 高 22.4 倍。同样,Western blot 显示 Hsp27 在 UM-SCC-22A 中几乎检测不到,而 UM-SCC-22B 表达的 Hsp27 蛋白水平高 25 倍。UM-SCC-22B 中的 Hsp27 的 siRNA 介导的敲低使 Hsp27 mRNA 表达降低近 6 倍,蛋白表达降低 23 倍。此外,Hsp27 的 siRNA 敲低使 UM-SCC-22B 的迁移和侵袭行为降低了 3-4 倍和 2 倍,使细胞侵袭和迁移降低至与原发性 HNSCC UM-SCC-22A 相似的水平。这些数据表明 Hsp27 可能调节 HNSCC 癌细胞的转移潜力。针对 Hsp27 可能会降低头颈部鳞状细胞癌中的转移。